Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Cardiovascular Translational Research
Published in: Journal of Cardiovascular Translational Research 4/2009

01-12-2009

Evolving Anatomic, Functional, and Molecular Imaging in the Early Detection and Prognosis of Hypertrophic Cardiomyopathy

Authors: Valentin Fuster, Sarina van der Zee, Marc A. Miller

Published in: Journal of Cardiovascular Translational Research | Issue 4/2009

Login to get access

Abstract

Evolving imaging modalities in hypertrophic cardiomyopathy (HCM), such as tissue Doppler, speckle tracking, measures of myocardial blood flow, and cardiac magnetic resonance with gadolinium enhancement, have advanced our understanding of the pathogenesis of myocardial dysfunction in hypertrophic cardiomyopathy. These modalities have the potential to differentiate HCM from other causes of left ventricular hypertrophy when there is uncertainty about the diagnosis and to identify affected individuals in the pre-clinical phase of the disease process. Furthermore, preliminary data suggests that functional imaging techniques may add incremental value to conventional risk stratification tools to identify individuals at high risk for sudden death or progression to congestive heart failure.
Literature
1.
Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T. T., & Bild, D. E. (1995). Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation, 92, 785–789.PubMed
2.
Klues, H. G., Schiffers, A., & Maron, B. J. (1995). Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. Journal of the American College of Cardiology, 26, 1699–1708.CrossRefPubMed
3.
Binder, J., Ommen, S. R., Gersh, B. J., et al. (2006). Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations. Mayo Clinic Proceedings, 81, 459–467.CrossRefPubMed
4.
Urheim, S., Edvardsen, T., Torp, H., Angelsen, B., & Smiseth, O. A. (2000). Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation, 102, 1158–1164.PubMed
5.
Van de Veire, N. R., De Sutter, J., Bax, J. J., & Roelandt, J. R. (2008). Technological advances in tissue Doppler imaging echocardiography. Heart, 94, 1065–1074.CrossRefPubMed
6.
Efthimiadis, G. K., Giannakoulas, G., Parharidou, D. G., et al. (2006). Prevalence of systolic impairment in an unselected regional population with hypertrophic cardiomyopathy. American Journal of Cardiology, 98, 1269–1272.CrossRefPubMed
7.
Burns, A. T., McDonald, I. G., Thomas, J. D., Macisaac, A., & Prior, D. (2008). Doin' the twist: New tools for an old concept of myocardial function. Heart, 94, 978–983.CrossRefPubMed
8.
Sun, J. P., Stewart, W. J., Yang, X. S., et al. (2009). Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. American Journal of Cardiology, 103, 411–415.CrossRefPubMed
9.
Bayrak, F., Kahveci, G., Mutlu, B., Sonmez, K., & Degertekin, M. (2008). Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy. European Journal of Echocardiography, 9, 278–283.CrossRefPubMed
10.
Nesbitt, G. C., Mankad, S., & Oh, J. K. (2009). Strain imaging in echocardiography: Methods and clinical applications. International Journal of Cardiovascular Imaging, 25(Suppl 1), 9–22.CrossRefPubMed
11.
Soor, G. S., Luk, A., Ahn, E., et al. (2009). Hypertrophic cardiomyopathy: Current understanding and treatment objectives. Journal of Clinical Pathology, 62, 226–235.CrossRefPubMed
12.
Nagueh, S. F., McFalls, J., Meyer, D., et al. (2003). Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation, 108, 395–398.CrossRefPubMed
13.
Nagueh, S. F., Bachinski, L. L., Meyer, D., et al. (2001). Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation, 104, 128–130.PubMed
14.
Ho, C. Y., Sweitzer, N. K., McDonough, B., et al. (2002). Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation, 105, 2992–2997.CrossRefPubMed
15.
Michels, M., Soliman, O. I., Kofflard, M. J., et al. (2009). Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovascular Imaging, 2, 58–64.CrossRefPubMed
16.
Buakhamsri, A., Popovic, Z. B., Lin, J., et al. (2009). Impact of left ventricular volume/mass ratio on diastolic function. European Heart Journal, 30, 1213–1221.CrossRefPubMed
17.
Richard, P., Charron, P., Carrier, L., et al. (2003). Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation, 107, 2227–2232.CrossRefPubMed
18.
Kubo, T., Gimeno, J. R., Bahl, A., et al. (2007). Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. Journal of the American College of Cardiology, 49, 2419–2426.CrossRefPubMed
19.
Du, J., Zhang, C., Liu, J., Sidky, C., & Huang, X. P. (2006). A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice. Archives of Biochemistry and Biophysics, 456, 143–150.CrossRefPubMed
20.
Geske, J. B., Sorajja, P., Nishimura, R. A., & Ommen, S. R. (2007). Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: Correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation, 116, 2702–2708.CrossRefPubMed
21.
Krasnow, N. (1997). Subaortic septal bulge simulates hypertrophic cardiomyopathy by angulation of the septum with age, independent of focal hypertrophy. An echocardiographic study. Journal of the American Society of Echocardiography, 10, 545–555.CrossRefPubMed
22.
Chen-Tournoux, A., Fifer, M. A., Picard, M. H., & Hung, J. (2008). Use of tissue Doppler to distinguish discrete upper ventricular septal hypertrophy from obstructive hypertrophic cardiomyopathy. American Journal of Cardiology, 101, 1498–1503.CrossRefPubMed
23.
Vinereanu, D., Florescu, N., Sculthorpe, N., Tweddel, A. C., Stephens, M. R., & Fraser, A. G. (2001). Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. American Journal of Cardiology, 88, 53–58.CrossRefPubMed
24.
Shan, K., Bick, R. J., Poindexter, B. J., et al. (2000). Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. Journal of the American College of Cardiology, 36, 891–896.CrossRefPubMed
25.
Yang, H., Sun, J. P., Lever, H. M., et al. (2003). Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. Journal of the American Society of Echocardiography, 16, 233–239.CrossRefPubMed
26.
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., et al. (2009). Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Journal of the American Society of Echocardiography, 22, 107–133.CrossRefPubMed
27.
van Dalen, B. M., Kauer, F., Soliman, O. I., et al. (2009). Influence of the pattern of hypertrophy on left ventricular twist in hypertrophic cardiomyopathy. Heart, 95, 657–661.CrossRefPubMed
28.
Greenberg, N. L., Firstenberg, M. S., Castro, P. L., et al. (2002). Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation, 105, 99–105.CrossRefPubMed
29.
Popovic, Z. B., Kwon, D. H., Mishra, M., et al. (2008). Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. Journal of the American Society of Echocardiography, 21, 1299–1305.CrossRefPubMed
30.
Adabag, A. S., Maron, B. J., Appelbaum, E., et al. (2008). Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. Journal of the American College of Cardiology, 51, 1369–1374.CrossRefPubMed
31.
Miller, M. A., Gomes, J. A., & Fuster, V. (2007). Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy. Nat Clin Pract Cardiovasc Med, 4, 667–676.CrossRefPubMed
32.
Gorcsan, J., 3 rd, Abraham, T., Agler, D. A., et al. (2008). Echocardiography for cardiac resynchronization therapy: Recommendations for performance and reporting—A report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. Journal of the American Society of Echocardiography, 21, 191–213.CrossRefPubMed
33.
D'Andrea, A., Caso, P., Severino, S., et al. (2006). Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. European Heart Journal, 27, 1311–1318.CrossRefPubMed
34.
Maron, B. J., Olivotto, I., Spirito, P., et al. (2000). Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation, 102, 858–864.PubMed
35.
D'Andrea, A., Caso, P., Severino, S., et al. (2005). Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy. Echocardiography, 22, 571–578.CrossRefPubMed
36.
Nagakura, T., Takeuchi, M., Yoshitani, H., et al. (2007). Hypertrophic cardiomyopathy is associated with more severe left ventricular dyssynchrony than is hypertensive left ventricular hypertrophy. Echocardiography, 24, 677–684.CrossRefPubMed
37.
Kato, T. S., Izawa, H., Komamura, K., et al. (2008). Heterogeneity of regional systolic function detected by tissue Doppler imaging is linked to impaired global left ventricular relaxation in hypertrophic cardiomyopathy. Heart, 94, 1302–1306.CrossRefPubMed
38.
Cleland, J. G., Daubert, J. C., Erdmann, E., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352, 1539–1549.CrossRefPubMed
39.
Sanderson, J. E. (2009). Echocardiography for cardiac resynchronization therapy selection: fatally flawed or misjudged? Journal of the American College of Cardiology, 53, 1960–1964.CrossRefPubMed
40.
Maron, M. S., Olivotto, I., Maron, B. J., et al. (2009). The case for myocardial ischemia in hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 54, 866–875.CrossRefPubMed
41.
Maron, B. J., Wolfson, J. K., Epstein, S. E., & Roberts, W. C. (1986). Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 8, 545–557.PubMed
42.
Basso, C., Thiene, G., Corrado, D., Buja, G., Melacini, P., & Nava, A. (2000). Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Human Pathology, 31, 988–998.CrossRefPubMed
43.
Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003). Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. New England Journal of Medicine, 349, 1027–1035.CrossRefPubMed
44.
Pitcher, D., Wainwright, R., Maisey, M., Curry, P., & Sowton, E. (1980). Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. British Heart Journal, 44, 650–656.CrossRefPubMed
45.
Camici, P. G., & Crea, F. (2007). Coronary microvascular dysfunction. New England Journal of Medicine, 356, 830–840.CrossRefPubMed
46.
Cannon, R. O., 3 rd, Dilsizian, V., O'Gara, P. T., et al. (1991). Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation, 83, 1660–1667.PubMed
47.
Grover-McKay, M., Schwaiger, M., Krivokapich, J., Perloff, J. K., Phelps, M. E., & Schelbert, H. R. (1989). Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 13, 317–324.PubMed
48.
Choudhury, L., Rosen, S. D., Patel, D., Nihoyannopoulos, P., & Camici, P. G. (1997). Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. European Heart Journal, 18, 108–116.PubMed
49.
Kawada, N., Sakuma, H., Yamakado, T., et al. (1999). Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects. Radiology, 211, 129–135.PubMed
50.
Radvan, J., Choudhury, L., Sheridan, D. J., & Camici, P. G. (1997). Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy. American Journal of Cardiology, 80, 1621–1623.CrossRefPubMed
51.
Sharma, S., Elliott, P. M., Whyte, G., et al. (2000). Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. Journal of the American College of Cardiology, 36, 864–870.CrossRefPubMed
52.
Sardanelli, F., Molinari, G., Petillo, A., et al. (1993). MRI in hypertrophic cardiomyopathy: A morphofunctional study. Journal of Computer Assisted Tomography, 17, 862–872.CrossRefPubMed
53.
Rickers, C., Wilke, N. M., Jerosch-Herold, M., et al. (2005). Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation, 112, 855–861.CrossRefPubMed
54.
Moon, J. C., Fisher, N. G., McKenna, W. J., & Pennell, D. J. (2004). Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart, 90, 645–649.CrossRefPubMed
55.
Zerhouni, E. A., Parish, D. M., Rogers, W. J., Yang, A., & Shapiro, E. P. (1988). Human heart: Tagging with MR imaging—A method for noninvasive assessment of myocardial motion. Radiology, 169, 59–63.PubMed
56.
Kuribayashi, T., & Roberts, W. C. (1992). Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. American Journal of Cardiology, 70, 1333–1340.CrossRefPubMed
57.
Heng, M. K., Janz, R. F., & Jobin, J. (1985). Estimation of regional stress in the left ventricular septum and free wall: An echocardiographic study suggesting a mechanism for asymmetric septal hypertrophy. American Heart Journal, 110, 84–90.CrossRefPubMed
58.
Lima, J. A., Judd, R. M., Bazille, A., Schulman, S. P., Atalar, E., & Zerhouni, E. A. (1995). Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation, 92, 1117–1125.PubMed
59.
Wu, E., Judd, R. M., Vargas, J. D., Klocke, F. J., Bonow, R. O., & Kim, R. J. (2001). Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet, 357, 21–28.CrossRefPubMed
60.
Roldan, V., Marin, F., Gimeno, J. R., et al. (2008). Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. American Heart Journal, 156, 85–91.CrossRefPubMed
61.
Esposito, A., De Cobelli, F., Perseghin, G., et al. (2009). Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Heart, 95, 228–233.CrossRefPubMed
62.
Choudhury, L., Mahrholdt, H., Wagner, A., et al. (2002). Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 40, 2156–2164.CrossRefPubMed
63.
Debl, K., Djavidani, B., Buchner, S., et al. (2006). Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: Visualisation of focal fibrosis. Heart, 92, 1447–1451.CrossRefPubMed
64.
Suk, T., Edwards, C., Hart, H., & Christiansen, J. P. (2008). Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients. Heart Lung Circ, 17, 370–374.CrossRefPubMed
65.
Jung, W. I., Sieverding, L., Breuer, J., et al. (2000). 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation, 101(12), E121. PMID: 9657474.
66.
de Roos A., Doornbos, J., Luyten, P. R., Oosterwaal, L. J., van der Wall, E. E., & den Hollander, J. (1992). Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. Journal of Magnetic Resonance Imaging, 2(6), 711-9. PMID: 1446116.
67.
Blackledge, M. J., Rajagopalan, B., Oberhaensli, R. D., Bolas, N. M., Styles, P., & Radda, G. K. (1987). Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR. Proceedings of the National Academy of Sciences of the United States of America, 84, 4283–4287.CrossRefPubMed
68.
Neubauer, S., Horn, M., Cramer, M., et al. (1997). Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation, 96, 2190–2196.PubMed
69.
Shivu, G. N., Abozguia, K., Phan, T. T., Ahmed, I., Henning, A., & Frenneaux, M. (2008). (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T. European Journal of Radiology, Dec. 2 [Epub ahead of print].
70.
Sieverding, L., Jung, W. I., Breuer, J., et al. (1997). Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy. American Journal of Cardiology, 80, 34A–40A.CrossRefPubMed
71.
Thet Thet, L., Takeda, T., Wu, J., et al. (2003). Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: Quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI. European Journal of Nuclear Medicine and Molecular Imaging, 30, 966–973.CrossRef
72.
Lefroy, D. C., de Silva, R., Choudhury, L., et al. (1993). Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: A study with positron emission tomography. Journal of the American College of Cardiology, 22, 1653–1660.PubMedCrossRef
Metadata
Title
Evolving Anatomic, Functional, and Molecular Imaging in the Early Detection and Prognosis of Hypertrophic Cardiomyopathy
Authors
Valentin Fuster
Sarina van der Zee
Marc A. Miller
Publication date
01-12-2009
Publisher
Springer US
Published in
Journal of Cardiovascular Translational Research / Issue 4/2009
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-009-9133-6

Other articles of this Issue 4/2009

Journal of Cardiovascular Translational Research 4/2009 Go to the issue

OriginalPaper

Microvascular Dysfunction, Myocardial Ischemia, and Progression to Heart Failure in Patients with Hypertrophic Cardiomyopathy

OriginalPaper

Response of Novel Biomarkers to BNP Infusion in Patients with Decompensated Heart Failure: A Multimarker Paradigm

OriginalPaper

The Left Ventricular Outflow in Hypertrophic Cardiomyopathy: From Structure to Function

OriginalPaper

Experimental Therapies in Hypertrophic Cardiomyopathy

OriginalPaper

Sudden Death in Hypertrophic Cardiomyopathy

OriginalPaper

Exercise in Hypertrophic Cardiomyopathy